Abstract
Driving under the influence of prescribed or illegal drugs increases the risk of having road accidents, just like driving under the influence of alcohol. In forensic toxicology, an increasing number of blood samples must be analyzed for drugs. Immunoassays tailored for a limited number of drugs (of abuse) are usually applied as prescreening tests at the roadside and/or in the laboratory. However, many other common drugs, such as anesthetics, antidepressants, antiepileptics, antihistamines, newer designer drugs, herbal drugs, neuroleptics (antipsychotics), opioids, or sedative-hypnotics, can also impair drivers. Therefore, this paper reviews multianalyte single-stage and tandem gas or liquid chromatography–mass spectrometry (GC-MS or LC-MS) procedures for the screening, identification, and validated quantification of such drugs in blood that have been reported since 2003. Basic information about the biosample assayed, workup, chromatography, the mass spectral detection mode, and validation data is summarized in tables. The pros and cons of the reviewed procedures are critically discussed, particularly with respect to their probable usefulness in impaired driving toxicology.
Similar content being viewed by others
References
Smink BE, Movig KL, Lusthof KJ, de Gier JJ, Uges DR, Egberts AC (2008) Traffic Inj Prev 9:105–108
Jones AW, Holmgren A, Kugelberg FC (2007) Ther Drug Monit 29:248–260
Augsburger M, Donze N, Menetrey A, Brossard C, Sporkert F, Giroud C, Mangin P (2005) Forensic Sci Int 153:11–15
Longo MC, Hunter CE, Lokan RJ, White JM, White MA (2000) Accid Anal Prev 32:623–632
The International Council on Alcohol, Drugs and Traffic Safety (2007) Guidelines for drugged driving research. http://international.drugabuse.gov/information/PDFs/TalloiresReport.pdf. Last accessed 13 August 2008
Schweizerische Fachstelle fuer Alkohol- und andere Drogenprobleme (2007) Alkohol, illegale Drogen und Medikamente im Strassenverkehr. http://www.sfa-ispa.ch/DocUpload/di_strassenverkehr.pdf. Last accessed 13 August 2008
Toennes SW, Kauert GF, Steinmeyer S, Moeller MR (2005) Forensic Sci Int 152:149–155
Logan BK (2007) Toxicological considerations in impaired driving research and enforcement: sample selection. In: The International Council on Alcohol, Drugs and Traffic Safety (ed) Guidelines for drugged driving research. ICADTS, Nydalen, Norway, pp 17–22 (see http://international.drugabuse.gov/information/PDFs/TalloiresReport.pdf, last accessed 13 August 2008)
Farrell LJ, Kerrigan S, Logan BK (2007) J Forensic Sci 52:1214–1218
Moeller MR, Kraemer T (2002) Ther Drug Monit 24:210–221
Steinmeyer S, Ohr H, Maurer HJ, Moeller MR (2001) Forensic Sci Int 121:33–36
Crouch DJ, Walsh JM, Cangianelli L, Quintela O (2008) Ther Drug Monit 30:188–195
Drummer OH (2008) Ther Drug Monit 30:203–206
Lillsunde P (2008) Ther Drug Monit 30:181–187
Pil K, Verstraete A (2008) Ther Drug Monit 30:196–202
Maurer HH (2007) Anal Bioanal Chem 388:1315–1325
Samyn N, Laloup M, de Boeck G (2007) Anal Bioanal Chem 388:1437–1453
Drummer OH (2006) Clin Biochem Rev 27:147–159
Maurer HH (2006) J Mass Spectrom 41:1399–1413
Pragst F, Balikova MA (2006) Clin Chim Acta 370:17–49
Maurer HH (2004) Clin Chem Lab Med 42:1310–1324
Kraemer T, Paul LD (2007) Anal Bioanal Chem 388:1415–1435
Schwilke EW, Sampaio dos Santos MI, Logan BK (2006) J Forensic Sci 51:1191–1198
Kroener L, Musshoff F, Madea B (2003) J Anal Toxicol 27:205–212
Maurer HH (2005) Anal Bioanal Chem 381:110–118
Maurer HH (2005) Clin Biochem 38:310–318
Drummer OH (2007) Anal Bioanal Chem 388:1495–1503
Dams R, Huestis MA, Lambert WE, Murphy CM (2003) J Am Soc Mass Spectrom 14:1290–1294
Wille SM, Lambert WE (2007) Anal Bioanal Chem 388:1381–1391
Pragst F (2007) Anal Bioanal Chem 388:1393–1414
Hoja H, Marquet P, Verneuil B, Lotfi H, Penicaut B, Lachatre G (1997) J Anal Toxicol 21:116–126
Moeller MR, Steinmeyer S, Kraemer T (1998) J Chromatogr B 713:91–109
Maurer HH (1998) J Chromatogr B 713:3–25
Van Bocxlaer JF, Clauwaert KM, Lambert WE, Deforce DL, Van den Eeckhout EG, De Leenheer AP (2000) Mass Spectrom Rev 19:165–214
Marquet P (2002) Ther Drug Monit 24:255–276
Hernandez F, Sancho JV, Pozo OJ (2005) Anal Bioanal Chem 382:934–946
Maurer HH (2005) Ann Toxicol Anal 17:13–20
Wood M, Laloup M, Samyn N, Mar Ramirez FM, De Bruijn EA, Maes RA, de Boeck G (2006) J Chromatogr A 1130:3–15
Peters FT, Maurer HH (2002) Accred Qual Assur 7:441–449
Peters FT, Drummer OH, Musshoff F (2007) Forensic Sci Int 165:216–224
Lindner W, Wainer IW (1998) J Chromatogr B 707:1–2
Maurer HH (2007) Forensic screening with GC-MS. In: Bogusz M (ed) Handbook of analytical separation sciences: forensic sciences, 2nd edn. Elsevier, Amsterdam, pp 429–449
Maurer HH, Pfleger K, Weber AA (2007) Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites. Wiley-VCH, Weinheim
Mueller CA, Weinmann W, Dresen S, Schreiber A, Gergov M (2005) Rapid Commun Mass Spectrom 19:1332–1338
Sauvage FL, Saint-Marcous F, Duretz B, Deporte D, Lachatre G, Marquet P (2006) Clin Chem 52:1735–1742
Gunnar T, Mykkanen S, Ariniemi K, Lillsunde P (2004) J Chromatogr B 806:205–219
Saint-Marcoux F, Lachatre G, Marquet P (2003) J Am Soc Mass Spectrom 14:14–22
Maurer HH, Peters FT (2005) Ther Drug Monit 27:686–688
Herrin GL, McCurdy HH, Wall WH (2005) J Anal Toxicol 29:599–606
Reubsaet JL, Pedersen-Bjergaard S (2004) J Chromatogr A 1031:203–211
Peters FT (2006) Method validation using LC-MS. In: Polettini A (ed) Applications of liquid chromatography–mass spectrometry in toxicology. Pharmaceutical Press, London, pp 71–95
Annesley TM (2003) Clin Chem 49:1041–1044
Liang HR, Foltz RL, Meng M, Bennett P (2003) Rapid Commun Mass Spectrom 17:2815–2821
Maurer HH, Kraemer T, Springer D, Staack RF (2004) Ther Drug Monit 26:127–131
Peters FT, Schaefer S, Staack RF, Kraemer T, Maurer HH (2003) J Mass Spectrom 38:659–676
Habrdova V, Peters FT, Theobald DS, Maurer HH (2005) J Mass Spectrom 40:785–795
Kankaanpaa A, Gunnar T, Ariniemi K, Lillsunde P, Mykkanen S, Seppala T (2004) J Chromatogr B 810:57–68
Ishida T, Kudo K, Kiyoshima A, Inoue H, Tsuji A, Ikeda N (2005) J Chromatogr B 823:47–52
Vorce SP, Sklerov JH (2004) J Anal Toxicol 28:407–410
Toennes SW, Kauert GF (2004) Forensic Sci Int 140:85–90
Beyer J, Peters FT, Kraemer T, Maurer HH (2007) J Mass Spectrom 42:150–160
Beyer J, Peters FT, Kraemer T, Maurer HH (2007) J Mass Spectrom 42:621–633
Kratzsch C, Weber AA, Peters FT, Kraemer T, Maurer HH (2003) J Mass Spectrom 38:283–295
Kratzsch C, Tenberken O, Peters FT, Weber AA, Kraemer T, Maurer HH (2004) J Mass Spectrom 39:856–872
Maurer HH, Kratzsch C, Kraemer T, Peters FT, Weber AA (2002) J Chromatogr B 773:63–73
Maurer HH, Tenberken O, Kratzsch C, Weber AA, Peters FT (2004) J Chromatogr A 1058:169–181
Jones AW, Holmgren A, Kugelberg FC (2007) J Anal Toxicol 31:566–572
Kankaanpaa A, Liukkonen R, Ariniemi K (2007) Forensic Sci Int 170:133–138
Villain M, Cirimele V, Ludes B, Kintz P (2003) J Chromatogr B 792:83–87
Paul R, Tsanaclis L, Kingston R, Berry A, Guwy A (2006) J Anal Toxicol 30:375–379
Kaufmann E, Alt A (2007) Forensic Sci Int 168:133–137
Feng N, Vollenweider FX, Minder EI, Rentsch K, Grampp T, Vonderschmitt DJ (1995) Ther Drug Monit 17:95–100
Rodriguez Rosas ME, Patel S, Wainer IW (2003) J Chromatogr B 794:99–108
Musshoff F, Trafkowski J, Kuepper U, Madea B (2006) J Mass Spectrom 41:633–640
Al Asmari AI, Anderson RA (2007) J Anal Toxicol 31:394–408
Gunnar T, Ariniemi K, Lillsunde P (2006) J Mass Spectrom 41:741–754
Quintela O, Cruz A, Castro A, Concheiro M, Lopez-Rivadulla M (2005) J Chromatogr B 825:63–71
Bugey A, Rudaz S, Staub C (2006) J Chromatogr B 832:249–255
Smink BE, Brandsma JE, Dijkhuizen A, Lusthof KJ, de Gier JJ, Egberts AC, Uges DR (2004) J Chromatogr B 811:13–20
Laloup M, Ramirez Fernandez MM, de Boeck G, Wood M, Maes V, Samyn N (2005) J Anal Toxicol 29:616–626
Miyaguchi H, Kuwayama K, Tsujikawa K, Kanamori T, Iwata YT, Inoue H, Kishi T (2006) Forensic Sci Int 157:57–70
Hori Y, Fujisawa M, Shimada K, Hirose Y, Yoshioka T (2006) Biol Pharm Bull 29:7–13
Theunissen EL, Vermeeren A, Ramaekers JG (2006) Br J Clin Pharmacol 61:79–86
Hasegawa C, Kumazawa T, Lee XP, Fujishiro M, Kuriki A, Marumo A, Seno H, Sato K (2006) Rapid Commun Mass Spectrom 20:537–543
Subramanian M, Birnbaum AK, Remmel RP (2008) Ther Drug Monit 30:347–356
Sauvage FL, Gaulier JM, Lachatre G, Marquet P (2006) Ther Drug Monit 28:123–130
Juan H, Zhiling Z, Huande L (2005) J Chromatogr B 820:33–39
Alves C, Santos-Neto AJ, Fernandes C, Rodrigues JC, Lancas FM (2007) J Mass Spectrom 42:1342–1347
de Castro A, Ramirez Fernandez MM, Laloup M, Samyn N, de Boeck G, Wood M, Maes V, Lopez-Rivadulla M (2007) J Chromatogr A 1160:3–12
Titier K, Castaing N, Le Deodic M, Le bars D, Moore N, Molimard M (2007) J Anal Toxicol 31:200–207
Castaing N, Titier K, Receveur-Daurel M, Le Deodic M, Le bars D, Moore N, Molimard M (2007) J Anal Toxicol 31:334–341
Kirchherr H, Kuhn-Velten WN (2006) J Chromatogr B 843:100–113
Roman M, Kronstrand R, Lindstedt D, Josefsson M (2008) J Anal Toxicol 32:147–155
Acknowledgements
The author would like to thank Prof. Dr. Thomas Kraemer and Dr. Frank T. Peters for their suggestions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maurer, H.H. Mass spectrometric approaches in impaired driving toxicology. Anal Bioanal Chem 393, 97–107 (2009). https://doi.org/10.1007/s00216-008-2338-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-008-2338-8